When the families behind some of the world’s biggest fortunes decide change is needed in their business empires, they’re increasingly turning to large private equity giants.
On Saturday, Illinois-based Medline Industries, a family-owned maker of medical equipment like masks, surgical gowns, drapes, sanitizing products and biohazard bags, sold itself for about $30 billion to a consortium of private equity firms including Blackstone Group, Carlyle Group and Hellman & Friedman. After a hotly fought over negotiations involving other blue chip bidders, the winners have struck the largest buyout deal since the 2008 financial crisis, and one that rekindles memories of the “club deals” of the 2000s leveraged buyout boom.
For the family behind Medline, the LBO will be an enormous windfall. Owned by the Mills family—Andy Mills is president, his cousin Charlie Mills is CEO and Andy’s brother-in-law Jim Abrams is COO—they will sell a majority of Medline to the private equity consortium and receive pre-tax proceeds of over $22 billion, according to Forbes estimates. Collectively, the Mills family retain just over 25% ownership in Medline, continue to run the company under existing management, and remain its largest singe shareholder. (Medline, through a spokesperson, declined to comment on our estimates.)
Read more/Source: Forbes
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.